Market revenue in 2023 | USD 594.2 million |
Market revenue in 2030 | USD 1,041.2 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Regulatory writing & publishing |
Fastest growing segment | Legal Representation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Other Services |
Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Icon PLC, Wuxi AppTec Co Ltd, Charles River Laboratories International Inc, Cencora Inc, Pharmexon, Genpact Ltd, Freyr Solutions, PAREXEL |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical regulatory affairs market will help companies and investors design strategic landscapes.
Regulatory writing & publishing was the largest segment with a revenue share of 36.54% in 2023. Horizon Databook has segmented the Japan pharmaceutical regulatory affairs market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is the second largest pharmaceutical market, followed by the U.S. The well-established pharmaceutical industry in Japan is the major factor driving the pharmaceutical regulatory affairs market.
The country is expected to dominate the pharmaceutical regulatory affairs market during the forecast period in Asia Pacific due to the rising demand for new and cost-effective medicines, which may attract investments from biopharmaceutical companies.
Rising demand for generics due to government support and improvement in regulatory approval processes are expected to increase the number of market entrants, propelling the demand for regulatory services. Increasing costs of R&D and pricing pressure may restrain the growth of the regulatory outsourcing market in this country.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan pharmaceutical regulatory affairs market , including forecasts for subscribers. This country databook contains high-level insights into Japan pharmaceutical regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account